Total Funding
88
45
Total FundingVenture - Series Unknown raised
Growth Score
-8 pts
Heat Score
-48 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
31572
Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.
- Todd Ridky: Co-founder
- Patrick Mooney: CEOPast Role: Echo Therapeutics, CEO, President, Chairman
About the Company
Linnaeus Therapeutics is a development stage biotech company engaged in the identification and development of small molecule agents that modulate cellular differentiation for the treatment of cancer and disorders of pigmentation.Linnaeus is a Penn Center for Innovation UPstart company that was founded in 2016 and is based upon discoveries from the
Ridky lab at the University of Pennsylvania.
